Skip to Content

CALAMINE CREAM AQUEOUS BP

Active substance(s): CALAMINE / ZINC OXIDE

View full screen / Print PDF » Download PDF ⇩
Transcript
11 mm

4,5 mm
4,5 mm

27,2 mm
27,2 mm
110,2 mm

Colours Used

Product
Title

Care Aqueous Calamine Cream

Component

Tube

PANTONE 661 C

Pack Size

100g

PANTONE 640 C

IG Code

24712801

PANTONE Purple C

Dimensions

35 x 141mm

Keyline (Does not print)

Proof No.

1

PANTONE Orange 021 C

Date

Print Free Area

20.09.2013

Data Matrix: 24712801 VERIFIED

PCP Header Box
Operator

Approved by
Date

gill.kennedy

Artwork No 462061
Suf fix

CRN

8136

Reason for
Change

Re-introduction of this pack
moving from tubs to tubes.
Substitute to amend cutter profile
as request of Albea 20.6.12.
Temporary Procedure Form
Ref: 134, CRN: 10502

N/A

Issued by
Date

MHRA/IMB
submission N/A
required

Fonts Used

Helvetica

18,6 mm

MHRA Header Box

27,2 mm

18,6 mm
22,6 mm

5,5 mm

146,05 mm

Braille Reads
q

u

e

o

u

s

c

a

l

a

m

i

n

e

c

r

e

a

m

100g

Calamine, Zinc oxide
Relieves mild sunburn
& other minor skin
conditions

Aqueous
Calamine
Cream

a

Aqueous Calamine Cream

Calamine, Zinc oxide
Relieves mild sunburn & other minor skin conditions

! If you are having an X-ray, do not apply beforehand as it may affect the outcome

Calamine, Zinc oxide
Relieves mild sunburn & other
minor skin conditions

Read all the carton before use.
What the medicine is for

Aqueous
Calamine
Cream

100g
of the X-ray examination.

Aqueous Calamine Cream contains calamine and zinc oxide which have an
astringent action. The cream has a soothing effect on mild sunburn and other minor
skin conditions.

! Important ingredient information

Before you use this medicine

 How to use the medicine

• An allergy to phenoxyethanol or any other ingredient listed.

Apply the cream to the skin.
Adults, the elderly and children: Apply liberally to dry clean skin as required.

✗ Do not use the medicine if you or your child have….
! Pregnant or breastfeeding

Using Aqueous Calamine Cream during pregnancy and breastfeeding is unlikely to
have any ill effects when used as directed. If unsure, talk to your doctor or
pharmacist.

This medicine contains cetostearyl alcohol which may cause local skin reactions
(e.g. contact dermatitis).

FOR EXTERNAL USE ONLY.
! If you accidentally swallow some see a doctor straight away. Take the pack with
you to show which medicine you have swallowed.

Storing the medicine

Possible side effects
There are no known side effects from using Aqueous Calamine Cream as directed.
If you notice any side effects, stop use and tell your doctor or pharmacist. They will
tell you what to do.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes
any possible side effects not listed in this leaflet. You can also report side effects
directly via the yellow card scheme at: www.mhra.gov.uk/yellowcard
By reporting side effects you can help provide more information on the safety of
this medicine.

Do not store above 25°C. Keep securely closed when not in use. Do not allow to freeze.
Keep out of the sight and reach of children. Use by the date shown on the side of the carton.
Active ingredients: calamine 4%w/w, zinc oxide 3%w/w.
Also contains: liquid paraffin, glyceryl monostearate (E471), macrogol cetostearyl
ether 22, cetostearyl alcohol, phenoxyethanol,
and purified water.
Manufactured by the licence holder:
Thornton and Ross Ltd., Huddersfield, HD7 5QH, UK.
PL 00240/6276R
Text revised in September 2014
24713602 5 011309 027419

MHRA Header Box
Colours Used

Fonts Used

Product
Title

Aqueous Calamine Cream Care

Process Cyan

Helvetica

Component

Carton

Process Magenta

Helvetica Neue

Pack Size

100g

Process Yellow

Helvetica Neue LT

IG Code

24713602

Process Black

OCRB

Dimensions

47 x 40 x 176mm

PANTONE 280 C

Times

Proof No.

3

PANTONE Purple C

Zapf Dingbats

Keyline (Does not print)

Zapf Dingbats ITCbyBT

Date

10.09.2014

Braille

PCP Header Box
Operator

Approved by
Date

gill.kennedy

Data Matrix: 24713602 VERIFIED

Artwork No 532173
Suf fix

CRN

11490

Reason for
Change

Addition of reporting of side
effects in line with MHRA
requirements.

A

Issued by
Date

MHRA/IMB
submission Yes
required

Braille Warning! Chesapeake cannot accept responsibility for any errors in this proof after approval by the customer.
Whilst extreme care is taken in the setting of Braille, the customer must take the final responsibility for its accuracy.
There is no single European Braille authority and there are many different Braille formats in existence, with country specific
characters.
This Braille is set to the Marburg Medium format unless you have requested otherwise.
When you sign this proof you are signifying full approval of the Braille text and specification.

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide